Inspire Investing’s MacroGenics MGNX Stock Holding History

Inspire Investing’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$51	Buy	18 +4	+29%	+$9	﹤0.01%	1072
2025 Q4	$23	Buy	+14	New	+$22	﹤0.01%	1100
2020 Q2	–	Sell	-43	Closed	–	–	626
2020 Q1	$0	Buy	+43	New	+$390	﹤0.01%	769
2018 Q1	–	Sell	-72	Closed	-$1K	–	496
2017 Q4	$1K	Buy	+72	New	+$1.34K	﹤0.01%	877

Other funds holding MGNX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Inspire Investing's MGNX Position: Q1 2026 in Review

Inspire Investing increased its MacroGenics (MGNX) stake by 29% in Q1 2026, buying an estimated $9 and bringing the position to 18 shares worth $51. The position accounts for ﹤0.01% of the portfolio, ranked #1072.

Inspire Investing first reported a position in MGNX in Q4 2017 and has held it in 4 quarters since. The position peaked at $1K in Q4 2017. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

Inspire Investing held 18 shares of MacroGenics worth $51 as of Q1 2026.
Inspire Investing bought 4 MacroGenics shares in Q1 2026, an estimated $9.
MacroGenics made up ﹤0.01% of Inspire Investing's portfolio in Q1 2026, its #1072 holding.
Inspire Investing first reported a position in MacroGenics in Q4 2017 and has held it in 4 quarters since.
Inspire Investing's MacroGenics position peaked at $1K in Q4 2017.
109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.